What is Tyson Foods' operating income?

Tyson Foods' total operating income in 2025 was $1.10 billion, based on the following breakdown: Total Gross Profit: $3.56 billion Total Operating Expenses: $2.46 billion

Tyson Foods (TSN) Financials

$55.43 +0.03 (+0.05%)

Closing price 08/28/2026 03:58 PM Eastern

Extended Trading

$55.48 +0.05 (+0.08%)

As of 07:37 AM Eastern

Compare

Annual Income Statements for Tyson Foods

This table shows Tyson Foods' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	9/27/2025
Net Income / (Loss) Attributable to Common Shareholders	1,220	1,768	1,774	2,970	1,980	2,061	3,047	3,238	-648	800	474
Consolidated Net Income / (Loss)	1,224	1,772	1,778	2,973	1,993	2,071	3,060	3,249	-649	822	507
Net Income / (Loss) Continuing Operations	1,224	1,772	1,778	2,973	1,993	2,071	3,060	3,249	-649	822	507
Total Pre-Tax Income	1,921	2,598	2,628	2,682	2,374	2,664	4,041	4,149	-678	1,092	769
Total Operating Income	2,169	2,833	2,921	2,969	2,770	3,008	4,396	4,410	-395	1,409	1,098
Total Gross Profit	3,917	4,697	5,062	5,096	5,022	5,384	6,526	6,668	2,631	3,627	3,562
Total Revenue	41,373	36,881	38,260	40,052	42,405	43,185	47,049	53,282	52,881	53,309	54,441
Operating Revenue	41,373	36,881	38,260	40,052	42,405	43,185	47,049	53,282	52,881	53,309	54,441
Total Cost of Revenue	37,456	32,184	33,198	34,956	37,383	37,801	40,523	46,614	50,250	49,682	50,879
Operating Cost of Revenue	37,456	32,184	33,198	34,956	37,383	37,801	40,523	46,614	50,250	49,682	50,879
Total Operating Expenses	1,748	1,864	2,141	2,127	2,252	2,376	2,130	2,258	3,026	2,218	2,464
Selling, General & Admin Expense	1,748	1,864	2,141	2,127	2,252	2,376	2,130	2,258	2,245	2,218	2,121
Impairment Charge	-	-	-	-	-	-	0.00	0.00	781	0.00	343
Total Other Income / (Expense), net	-248	-235	-293	-287	-396	-344	-355	-261	-283	-317	-329
Interest Expense	293	249	279	350	462	485	428	365	355	481	449
Interest & Investment Income	9.00	6.00	7.00	7.00	11	10	8.00	17	30	89	73
Other Income / (Expense), net	36	8.00	-21	56	55	131	65	87	42	75	47
Income Tax Expense	697	826	850	-291	381	593	981	900	-29	270	262
Net Income / (Loss) Attributable to Noncontrolling Interest	4.00	4.00	4.00	3.00	13	10	13	11	-1.00	22	33
Basic Earnings per Share	$5.85	$8.91	-	$15.75	$10.55	$11.00	$0.00	-	($3.55)	$0.00	$2.59
Weighted Average Basic Shares Outstanding	405M	385M	398.70M	365M	363M	363M	0.00	0.00	354M	0.00	355M
Diluted Earnings per Share	$2.95	$4.53	$4.79	$8.04	$5.40	$5.64	$8.34	$8.92	($1.87)	$2.25	$1.33
Weighted Average Diluted Shares Outstanding	413M	390M	370M	369M	366M	365M	365M	363M	284M	356M	357M
Weighted Average Basic & Diluted Shares Outstanding	437.30M	417M	398.70M	398.40M	365.19M	364.14M	364.78M	0.00	0.00	0.00	353.05M

This table shows Tyson Foods' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026	6/27/2026
Net Income / (Loss) Attributable to Common Shareholders	107	145	191	357	359	7.00	61	47	85	260	182
Consolidated Net Income / (Loss)	114	148	196	364	366	14	69	58	90	264	186
Net Income / (Loss) Continuing Operations	114	148	196	364	366	14	69	58	90	264	186
Total Pre-Tax Income	161	203	253	475	478	30	193	68	127	359	266
Total Operating Income	231	312	341	525	580	100	260	158	302	435	362
Total Gross Profit	823	866	878	1,060	1,095	600	1,141	726	808	962	921
Total Revenue	13,319	13,072	13,353	13,565	13,623	13,074	13,884	13,860	14,313	13,653	13,868
Operating Revenue	13,319	13,072	13,353	13,565	13,623	13,074	13,884	13,860	14,313	13,653	13,868
Total Cost of Revenue	12,496	12,206	12,475	12,505	12,528	12,474	12,743	13,134	13,505	12,691	12,947
Operating Cost of Revenue	12,496	12,206	12,475	12,505	12,528	12,474	12,743	13,134	13,505	12,691	12,947
Total Operating Expenses	592	554	537	535	515	500	881	568	506	527	559
Selling, General & Admin Expense	592	554	537	535	515	500	538	568	506	527	559
Impairment Charge	-	-	0.00	-	-	-	343	-	-	-	0.00
Total Other Income / (Expense), net	-70	-109	-88	-50	-102	-70	-67	-90	-175	-76	-96
Interest Expense	105	111	135	130	120	110	113	106	104	97	98
Interest & Investment Income	10	14	36	29	25	17	15	16	13	8.00	6.00
Other Income / (Expense), net	25	-12	11	51	-7.00	23	31	-	-84	13	-4.00
Income Tax Expense	47	55	57	111	112	16	124	10	37	95	80
Net Income / (Loss) Attributable to Noncontrolling Interest	7.00	3.00	5.00	7.00	7.00	7.00	8.00	11	5.00	4.00	4.00
Basic Earnings per Share	$0.59	$0.00	$1.04	-	$0.00	$0.00	$0.00	$0.29	$0.47	$1.43	$0.00
Weighted Average Basic Shares Outstanding	354M	0.00	354M	0.00	0.00	0.00	0.00	355M	352M	353M	0.00
Diluted Earnings per Share	$0.30	$0.41	$0.54	$1.00	$1.01	$0.02	$0.17	$0.13	$0.24	$0.73	$0.52
Weighted Average Diluted Shares Outstanding	355M	355M	356M	356M	357M	357M	357M	357M	354M	354M	355M
Weighted Average Basic & Diluted Shares Outstanding	356.35M	356.02M	355.83M	0.00	356.19M	356.23M	355.77M	353.05M	352.08M	352.13M	351.80M

This table details how cash moves in and out of Tyson Foods' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	9/27/2025
Net Change in Cash & Equivalents	250	-339	-31	-48	214	982	1,171	-1,606	-458	1,144	-488
Net Cash From Operating Activities	2,570	2,716	2,599	2,963	2,513	3,874	3,840	2,687	1,752	2,590	2,155
Net Cash From Continuing Operating Activities	2,570	2,716	2,599	2,963	2,513	3,874	3,845	2,700	1,752	2,590	2,155
Net Income / (Loss) Continuing Operations	1,224	1,772	1,778	2,973	1,993	2,071	3,060	3,249	-649	822	507
Consolidated Net Income / (Loss)	1,224	1,772	1,778	2,973	1,993	2,071	3,060	3,249	-649	822	507
Depreciation Expense	609	617	642	723	819	900	934	945	1,100	1,159	1,093
Amortization Expense	102	88	119	220	279	292	280	257	239	241	268
Non-Cash Adjustments To Reconcile Net Income	248	92	249	144	134	13	-690	76	875	189	469
Changes in Operating Assets and Liabilities, net	387	147	-189	-1,097	-712	598	261	-1,827	187	179	-182
Net Cash From Investing Activities	-270	-684	-4,164	-1,906	-3,464	-1,423	58	-1,935	-2,299	-888	-665
Net Cash From Continuing Investing Activities	-270	-684	-4,164	-1,906	-3,464	-1,423	58	-1,935	-2,299	-888	-665
Purchase of Property, Plant & Equipment	-854	-695	-1,069	-1,200	-1,259	-1,199	-1,209	-1,887	-1,939	-1,132	-978
Acquisitions	0.00	0.00	-3,081	-1,474	-2,462	-183	-44	-177	-377	-29	-11
Purchase of Investments	-38	-46	-79	-42	-64	-105	-72	-35	-34	-38	-66
Sale of Property, Plant & Equipment	-	-	-	-	-	-	-	-	0.00	0.00	252
Divestitures	539	0.00	0.00	797	170	29	1,188	0.00	0.00	174	0.00
Sale and/or Maturity of Investments	52	37	61	37	63	87	70	34	32	35	62
Other Investing Activities, net	31	20	4.00	-24	88	-52	125	130	19	102	76
Net Cash From Financing Activities	-2,035	-2,377	1,530	-1,102	1,171	-1,468	-2,731	-2,323	88	-581	-1,977
Net Cash From Continuing Financing Activities	-2,035	-2,377	1,530	-1,102	1,171	-1,468	-2,731	-2,323	88	-581	-1,977
Repayment of Debt	-3,323	-1,479	-12,852	-24,273	-21,630	-17,781	-2,654	-1,197	-7,722	-3,971	-1,280
Repurchase of Common Equity	-495	-1,944	-860	-427	-252	-207	-67	-702	-354	-49	-196
Payment of Dividends	-147	-216	-319	-431	-537	-601	-636	-653	-670	-684	-697
Issuance of Debt	1,846	1,134	15,407	23,927	23,491	17,091	585	103	8,823	4,109	175
Other Financing Activities, net	84	128	154	102	99	30	41	126	11	14	21
Effect of Exchange Rate Changes	-15	6.00	4.00	-3.00	-6.00	-1.00	4.00	-35	1.00	23	-1.00

This table details how cash moves in and out of Tyson Foods' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026	6/27/2026
Net Change in Cash & Equivalents	911	698	387	-852	575	-1,300	555	-318	49	-778	240
Net Cash From Operating Activities	1,300	-123	796	617	1,031	-185	774	535	942	-113	640
Net Cash From Continuing Operating Activities	1,300	-123	796	617	1,031	-185	774	535	942	-113	640
Net Income / (Loss) Continuing Operations	114	148	196	364	366	14	69	58	90	264	186
Consolidated Net Income / (Loss)	114	148	196	364	366	14	69	58	90	264	186
Depreciation Expense	373	349	360	77	348	352	329	64	376	350	329
Non-Cash Adjustments To Reconcile Net Income	129	-8.00	41	27	78	68	248	75	163	30	37
Changes in Operating Assets and Liabilities, net	684	-612	199	-92	239	-619	128	70	313	-757	88
Net Cash From Investing Activities	-378	-243	-233	-34	-233	-181	9.00	-260	-183	-116	-121
Net Cash From Continuing Investing Activities	-378	-243	-233	-34	-233	-181	9.00	-260	-183	-116	-121
Purchase of Property, Plant & Equipment	-354	-267	-263	-248	-271	-193	-227	-287	-252	-145	-159
Purchase of Investments	-7.00	-6.00	-10	-15	-15	-18	-17	-16	-21	-15	-13
Sale and/or Maturity of Investments	6.00	6.00	9.00	14	16	14	17	15	20	15	42
Other Investing Activities, net	3.00	24	33	42	37	16	-13	34	28	27	9.00
Net Cash From Financing Activities	-26	1,077	-168	-1,464	-195	-937	-245	-600	-718	-549	-279
Net Cash From Continuing Financing Activities	-26	1,077	-168	-1,464	-195	-937	-245	-600	-718	-549	-279
Repayment of Debt	-2,269	-291	-49	-1,362	-42	-775	-77	-386	-523	-1,793	-113
Repurchase of Common Equity	-13	-18	-13	-5.00	-15	-1.00	-26	-154	-47	-45	-31
Payment of Dividends	-171	-171	-171	-171	-175	-174	-175	-173	-177	-176	-176
Issuance of Debt	2,420	1,556	64	69	22	9.00	32	112	23	1,456	30
Other Financing Activities, net	7.00	1.00	1.00	5.00	15	4.00	1.00	1.00	6.00	9.00	11

This table presents Tyson Foods' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	9/27/2025
Total Assets	0.00	0.00	0.00	29,109	32,918	34,456	36,309	36,821	36,251	37,100	36,658
Total Current Assets	0.00	0.00	0.00	5,688	6,990	7,598	9,822	9,630	8,722	9,751	9,916
Cash & Equivalents	-	-	-	270	484	1,420	2,507	1,031	573	1,717	1,229
Accounts Receivable	-	-	-	1,723	2,173	1,952	2,400	2,577	2,476	2,406	2,524
Inventories, net	-	-	-	3,513	3,929	3,859	4,382	5,514	5,328	5,195	5,681
Other Current Assets	-	-	-	182	404	367	533	508	345	433	482
Plant, Property, & Equipment, net	0.00	0.00	0.00	6,169	7,282	7,596	7,837	8,685	9,634	9,442	9,204
Total Noncurrent Assets	0.00	0.00	0.00	17,252	18,646	19,262	18,650	18,506	17,895	17,907	17,538
Goodwill	-	-	-	9,739	10,844	10,899	10,549	10,513	9,878	9,819	9,469
Intangible Assets	-	-	-	6,759	7,037	6,774	6,519	6,252	6,098	5,875	5,624
Other Noncurrent Operating Assets	-	-	-	754	765	1,589	1,582	1,741	1,919	2,213	2,445
Total Liabilities & Shareholders' Equity	757	43	951	29,109	32,918	34,456	36,309	36,821	36,251	37,100	36,658
Total Liabilities	715	0.00	906	16,298	18,824	19,070	18,455	17,010	17,996	18,586	18,431
Total Current Liabilities	715	0.00	906	5,031	5,513	4,234	6,325	5,313	6,499	4,787	6,389
Short-Term Debt	715	-	906	1,911	2,102	548	1,067	459	1,895	74	909
Accounts Payable	-	-	-	1,694	1,926	1,876	2,225	2,483	2,594	2,402	2,601
Other Current Liabilities	-	-	-	1,426	1,485	1,810	3,033	2,371	2,010	2,311	2,879
Total Noncurrent Liabilities	0.00	0.00	0.00	11,267	13,311	14,836	12,130	11,697	11,497	13,799	12,042
Long-Term Debt	-	-	-	7,962	9,830	10,791	8,281	7,862	7,611	9,713	7,921
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	2,107	2,309	2,317	2,195	2,458	2,308	2,285	2,195
Other Noncurrent Operating Liabilities	-	-	-	1,198	1,172	1,728	1,654	1,377	1,578	1,801	1,926
Total Equity & Noncontrolling Interests	42	43	45	12,811	14,094	15,386	17,854	19,811	18,255	18,514	18,227
Total Preferred & Common Equity	42	43	45	12,803	13,950	15,254	17,723	19,702	18,133	18,390	18,085
Total Common Equity	42	43	45	12,758	13,950	15,254	17,723	19,702	18,133	18,390	18,085
Common Stock	42	43	45	4,387	4,423	4,478	4,531	4,598	4,605	4,642	4,731
Retained Earnings	-	-	-	12,329	13,655	15,100	17,502	20,084	18,760	18,873	18,647
Treasury Stock	-	-	-	-3,943	-4,011	-4,145	-4,138	-4,683	-4,972	-4,941	-5,102
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-15	-117	-179	-172	-297	-260	-184	-191
Noncontrolling Interest	-	-	-	8.00	144	132	131	109	122	124	142

This table presents Tyson Foods' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	12/27/2025	3/28/2026	6/27/2026
Total Assets	36,251	36,746	37,465	37,732	37,100	37,310	36,280	36,464	36,019	35,165	35,612
Total Current Assets	8,722	9,216	9,966	10,572	9,751	10,082	9,168	9,859	9,512	8,874	9,462
Cash & Equivalents	573	1,484	2,182	2,569	1,717	2,292	992	1,547	1,278	500	740
Accounts Receivable	2,476	2,263	2,358	2,389	2,406	2,323	2,385	2,454	2,429	2,399	2,457
Inventories, net	5,328	5,087	5,056	5,033	5,195	5,114	5,395	5,436	5,406	5,478	5,840
Other Current Assets	345	382	370	581	433	353	396	422	399	497	425
Plant, Property, & Equipment, net	9,634	9,672	9,593	9,368	9,442	9,353	9,278	9,081	9,064	8,917	8,789
Total Noncurrent Assets	17,895	17,858	17,906	17,792	17,907	17,875	17,834	17,524	17,443	17,374	17,361
Goodwill	9,878	9,885	9,878	9,801	9,819	9,805	9,805	9,468	9,474	9,472	9,469
Intangible Assets	6,098	6,046	5,985	5,928	5,875	5,799	5,740	5,683	5,577	5,526	5,475
Other Noncurrent Operating Assets	1,919	1,927	2,043	2,063	2,213	2,271	2,289	2,373	2,392	2,376	2,417
Total Liabilities & Shareholders' Equity	36,251	36,746	37,465	37,732	37,100	37,310	36,280	36,464	36,019	35,165	35,612
Total Liabilities	17,996	18,458	19,242	19,530	18,586	18,683	17,749	17,996	17,856	16,964	17,427
Total Current Liabilities	6,499	6,172	5,633	5,810	4,787	4,780	5,494	5,690	6,203	4,848	6,601
Short-Term Debt	1,895	1,308	1,315	1,320	74	95	896	886	909	141	1,427
Accounts Payable	2,594	2,623	2,244	2,291	2,402	2,497	2,350	2,373	2,723	2,467	2,761
Other Current Liabilities	2,010	2,241	2,074	2,199	2,311	2,188	2,248	2,431	2,571	2,240	2,413
Total Noncurrent Liabilities	11,497	12,286	13,609	13,720	13,799	13,903	12,255	12,306	11,653	12,116	10,826
Long-Term Debt	7,611	8,370	9,645	9,701	9,713	9,711	8,172	8,179	7,453	7,942	6,579
Noncurrent Deferred & Payable Income Tax Liabilities	2,308	2,302	2,292	2,318	2,285	2,283	2,240	2,217	2,205	2,216	2,233
Other Noncurrent Operating Liabilities	1,578	1,614	1,672	1,701	1,801	1,909	1,843	1,910	1,995	1,958	2,014
Total Equity & Noncontrolling Interests	18,255	18,288	18,223	18,202	18,514	18,627	18,531	18,468	18,163	18,201	18,185
Total Preferred & Common Equity	18,133	18,150	18,089	18,076	18,390	18,503	18,400	18,338	18,023	18,098	18,079
Total Common Equity	18,133	18,150	18,089	18,076	18,390	18,503	18,400	18,338	18,023	18,098	18,079
Common Stock	4,605	4,571	4,601	4,623	4,642	4,655	4,689	4,710	4,738	4,771	4,787
Retained Earnings	18,760	18,693	18,667	18,687	18,873	19,054	18,886	18,772	18,553	18,637	18,643
Treasury Stock	-4,972	-4,909	-4,927	-4,939	-4,941	-4,925	-4,922	-4,949	-5,125	-5,158	-5,183
Accumulated Other Comprehensive Income / (Loss)	-260	-205	-252	-295	-184	-281	-253	-195	-143	-152	-168
Noncontrolling Interest	122	138	134	126	124	124	131	130	140	103	106

This table displays calculated financial ratios and metrics derived from Tyson Foods' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	9/27/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.09%	-10.86%	3.74%	4.68%	5.87%	1.84%	8.95%	13.25%	-0.75%	0.81%	2.12%
EBITDA Growth	52.91%	21.60%	3.24%	8.39%	-1.13%	10.40%	31.03%	0.42%	-82.70%	192.49%	-13.11%
EBIT Growth	60.13%	28.84%	2.08%	4.31%	-6.61%	11.12%	42.12%	0.81%	-107.85%	520.40%	-22.84%
NOPAT Growth	41.35%	39.82%	2.27%	66.54%	-29.34%	0.56%	42.35%	3.74%	-108.01%	483.59%	-31.75%
Net Income Growth	42.99%	44.77%	0.34%	67.21%	-32.96%	3.91%	47.75%	6.18%	-119.98%	226.66%	-38.32%
EPS Growth	24.47%	53.56%	5.74%	67.85%	-32.84%	4.44%	47.87%	6.95%	-120.96%	220.32%	-40.89%
Operating Cash Flow Growth	118.17%	5.68%	-4.31%	14.01%	-15.19%	54.16%	-0.88%	-30.03%	-34.80%	47.83%	-16.80%
Free Cash Flow Firm Growth	41.35%	39.82%	2.27%	-1,067.64%	95.80%	420.90%	52.94%	-73.41%	-134.71%	557.94%	-11.10%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	13.96%	-0.93%	-2.41%	9.74%	0.32%	-2.22%	-2.84%
Revenue Q/Q Growth	0.98%	-3.53%	2.65%	-0.36%	2.13%	1.35%	2.96%	1.77%	-0.73%	0.41%	0.54%
EBITDA Q/Q Growth	14.00%	3.74%	6.12%	6.87%	0.33%	20.47%	28.54%	-13.80%	-46.88%	72.08%	-6.11%
EBIT Q/Q Growth	14.72%	1.21%	2.98%	3.70%	-8.13%	15.87%	28.01%	-20.98%	-141.05%	239.59%	-26.74%
NOPAT Q/Q Growth	7.85%	7.57%	1.25%	1.58%	-3.28%	15.62%	24.50%	-18.74%	-154.49%	924.51%	-28.52%
Net Income Q/Q Growth	11.17%	8.11%	0.17%	3.05%	-7.13%	18.75%	29.72%	-20.17%	-296.07%	5,380.00%	-37.64%
EPS Q/Q Growth	11.74%	9.69%	0.84%	3.21%	-7.38%	18.99%	29.91%	-19.86%	-303.26%	5,725.00%	-39.55%
Operating Cash Flow Q/Q Growth	11.40%	-1.98%	13.39%	-3.61%	-2.37%	5.10%	0.47%	-12.59%	-21.29%	12.80%	-3.67%
Free Cash Flow Firm Q/Q Growth	7.85%	7.57%	1.25%	-690.21%	96.64%	-3.74%	35.37%	-64.14%	-38.45%	69.77%	-11.95%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-2.96%	-1.41%	-2.90%	1.27%	-1.25%	-0.26%	-0.61%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.47%	12.74%	13.23%	12.72%	11.84%	12.47%	13.87%	12.51%	4.98%	6.80%	6.54%
EBITDA Margin	7.05%	9.61%	9.57%	9.91%	9.25%	10.03%	12.06%	10.70%	1.86%	5.41%	4.60%
Operating Margin	5.24%	7.68%	7.63%	7.41%	6.53%	6.97%	9.34%	8.28%	-0.75%	2.64%	2.02%
EBIT Margin	5.33%	7.70%	7.58%	7.55%	6.66%	7.27%	9.48%	8.44%	-0.67%	2.78%	2.10%
Profit (Net Income) Margin	2.96%	4.80%	4.65%	7.42%	4.70%	4.80%	6.50%	6.10%	-1.23%	1.54%	0.93%
Tax Burden Percent	63.72%	68.21%	67.66%	110.85%	83.95%	77.74%	75.72%	78.31%	95.72%	75.27%	65.93%
Interest Burden Percent	87.12%	91.45%	90.62%	88.66%	84.04%	84.87%	90.59%	92.26%	192.07%	73.58%	67.16%
Effective Tax Rate	36.28%	31.79%	32.34%	-10.85%	16.05%	22.26%	24.28%	21.69%	0.00%	24.73%	34.07%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	29.37%	9.70%	9.20%	13.32%	13.33%	-1.02%	3.94%	2.76%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	22.71%	6.54%	6.69%	10.11%	10.44%	-5.61%	1.14%	-0.01%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	16.88%	5.12%	4.85%	5.10%	3.92%	-2.39%	0.53%	0.00%
Return on Equity (ROE)	0.00%	0.00%	0.00%	46.25%	14.82%	14.05%	18.41%	17.25%	-3.41%	4.47%	2.76%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	-170.63%	-3.35%	10.13%	15.76%	4.04%	-1.34%	6.19%	5.65%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	20.78%	9.11%	9.32%	12.61%	12.30%	-0.97%	4.05%	3.10%
Return on Assets (ROA)	0.00%	0.00%	0.00%	20.43%	6.43%	6.15%	8.65%	8.89%	-1.78%	2.24%	1.37%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	46.06%	14.71%	13.92%	18.27%	17.14%	-3.39%	4.44%	2.74%
Return on Equity Simple (ROE_SIMPLE)	2,914.29%	4,120.93%	3,951.11%	23.22%	14.29%	13.58%	17.27%	16.49%	-3.58%	4.47%	0.00%
Net Operating Profit after Tax (NOPAT)	1,382	1,932	1,976	3,291	2,325	2,338	3,329	3,453	-277	1,061	724
NOPAT Margin	3.34%	5.24%	5.17%	8.22%	5.48%	5.41%	7.08%	6.48%	-0.52%	1.99%	1.33%
Net Nonoperating Expense Percent (NNEP)	-376.23%	-377.14%	-450.53%	6.66%	3.16%	2.50%	3.21%	2.89%	4.59%	2.81%	2.77%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	2.68%
Cost of Revenue to Revenue	90.53%	87.26%	86.77%	87.28%	88.16%	87.53%	86.13%	87.49%	95.02%	93.20%	93.46%
SG&A Expenses to Revenue	4.23%	5.05%	5.60%	5.31%	5.31%	5.50%	4.53%	4.24%	4.25%	4.16%	3.90%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.23%	5.05%	5.60%	5.31%	5.31%	5.50%	4.53%	4.24%	5.72%	4.16%	4.53%
Earnings before Interest and Taxes (EBIT)	2,205	2,841	2,900	3,025	2,825	3,139	4,461	4,497	-353	1,484	1,145
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,916	3,546	3,661	3,968	3,923	4,331	5,675	5,699	986	2,884	2,506
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	325.92	530.66	474.81	1.46	1.95	1.27	1.48	1.12	0.96	1.15	1.07
Price to Tangible Book Value (P/TBV)	325.92	530.66	474.81	0.00	0.00	0.00	40.14	7.53	8.03	7.88	6.44
Price to Revenue (P/Rev)	0.33	0.62	0.56	0.47	0.64	0.45	0.56	0.42	0.33	0.40	0.35
Price to Earnings (P/E)	11.22	12.91	12.04	6.29	13.75	9.41	8.63	6.83	0.00	26.55	40.67
Dividend Yield	1.09%	0.97%	1.51%	2.20%	2.01%	3.16%	2.47%	2.99%	3.94%	3.28%	3.69%
Earnings Yield	8.91%	7.75%	8.30%	15.90%	7.27%	10.63%	11.59%	14.63%	0.00%	3.77%	2.46%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.26	1.52	1.16	1.35	1.09	0.97	1.11	1.05
Enterprise Value to Revenue (EV/Rev)	0.35	0.62	0.58	0.71	0.92	0.68	0.71	0.55	0.50	0.55	0.50
Enterprise Value to EBITDA (EV/EBITDA)	4.94	6.43	6.08	7.13	9.90	6.80	5.86	5.18	26.75	10.21	10.78
Enterprise Value to EBIT (EV/EBIT)	6.53	8.03	7.68	9.35	13.74	9.38	7.46	6.57	0.00	19.83	23.60
Enterprise Value to NOPAT (EV/NOPAT)	10.42	11.81	11.27	8.60	16.70	12.59	9.99	8.55	0.00	27.75	37.33
Enterprise Value to Operating Cash Flow (EV/OCF)	5.60	8.40	8.57	9.55	15.45	7.60	8.66	10.99	15.05	11.36	12.54
Enterprise Value to Free Cash Flow (EV/FCFF)	10.42	11.81	11.27	0.00	0.00	11.43	8.44	28.19	0.00	17.68	18.26
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	17.02	0.00	20.13	0.77	0.85	0.74	0.52	0.42	0.52	0.53	0.48
Long-Term Debt to Equity	0.00	0.00	0.00	0.62	0.70	0.70	0.46	0.40	0.42	0.52	0.43
Financial Leverage	-1.00	-1.00	-1.00	0.74	0.78	0.72	0.50	0.38	0.43	0.46	0.43
Leverage Ratio	0.00	0.00	0.00	2.26	2.31	2.29	2.13	1.94	1.92	1.99	2.01
Compound Leverage Factor	0.00	0.00	0.00	2.01	1.94	1.94	1.93	1.79	3.69	1.47	1.35
Debt to Total Capital	94.45%	0.00%	95.27%	43.52%	45.85%	42.43%	34.37%	29.58%	34.24%	34.58%	32.63%
Short-Term Debt to Total Capital	94.45%	0.00%	95.27%	8.42%	8.08%	2.05%	3.92%	1.63%	6.83%	0.26%	3.36%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	35.10%	37.77%	40.38%	30.44%	27.95%	27.42%	34.32%	29.28%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.04%	0.55%	0.49%	0.48%	0.39%	0.44%	0.44%	0.52%
Common Equity to Total Capital	5.55%	100.00%	4.73%	56.24%	53.60%	57.08%	65.15%	70.03%	65.32%	64.98%	66.84%
Debt to EBITDA	0.25	0.00	0.25	2.49	3.04	2.62	1.65	1.46	9.64	3.39	3.52
Net Debt to EBITDA	0.25	0.00	0.25	2.42	2.92	2.29	1.21	1.28	9.06	2.80	3.03
Long-Term Debt to EBITDA	0.00	0.00	0.00	2.01	2.51	2.49	1.46	1.38	7.72	3.37	3.16
Debt to NOPAT	0.52	0.00	0.46	3.00	5.13	4.85	2.81	2.41	-34.38	9.23	12.20
Net Debt to NOPAT	0.52	0.00	0.46	2.92	4.92	4.24	2.06	2.11	-32.31	7.61	10.50
Long-Term Debt to NOPAT	0.00	0.00	0.00	2.42	4.23	4.61	2.49	2.28	-27.53	9.16	10.94
Altman Z-Score	0.00	0.00	0.00	3.03	3.07	2.89	3.35	3.53	2.80	3.13	3.04
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.41%	0.73%	0.94%	0.79%	0.64%	0.61%	0.67%	0.72%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.00	0.00	1.13	1.27	1.79	1.55	1.81	1.34	2.04	1.55
Quick Ratio	0.00	0.00	0.00	0.40	0.48	0.80	0.78	0.68	0.47	0.86	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,382	1,932	1,976	-19,123	-803	2,575	3,939	1,047	-364	1,665	1,480
Operating Cash Flow to CapEx	300.94%	390.79%	243.12%	246.92%	199.60%	323.10%	317.62%	142.40%	90.36%	228.80%	296.83%
Free Cash Flow to Firm to Interest Expense	4.72	7.76	7.08	-54.64	-1.74	5.31	9.20	2.87	-1.02	3.46	3.30
Operating Cash Flow to Interest Expense	8.77	10.91	9.32	8.47	5.44	7.99	8.97	7.36	4.94	5.38	4.80
Operating Cash Flow Less CapEx to Interest Expense	5.86	8.12	5.48	5.04	2.71	5.52	6.15	2.19	-0.53	3.03	3.18
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	2.75	1.37	1.28	1.33	1.46	1.45	1.45	1.48
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	21.77	20.94	21.62	21.41	20.93	21.84	22.09
Inventory Turnover	0.00	0.00	0.00	0.00	10.05	9.71	9.83	9.42	9.27	9.44	9.36
Fixed Asset Turnover	0.00	0.00	0.00	0.00	6.31	5.81	6.10	6.45	5.77	5.59	5.84
Accounts Payable Turnover	0.00	0.00	0.00	0.00	20.65	19.88	19.76	19.80	19.80	19.89	20.34
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	16.77	17.43	16.88	17.05	17.44	16.71	16.53
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	36.33	37.60	37.11	38.74	39.38	38.65	39.01
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	17.67	18.36	18.47	18.43	18.44	18.35	17.95
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	35.43	36.68	35.53	37.36	38.38	37.02	37.59
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	0.00	0.00	22,414	25,542	25,305	24,695	27,101	27,188	26,584	25,828
Invested Capital Turnover	0.00	0.00	0.00	3.57	1.77	1.70	1.88	2.06	1.95	1.98	2.08
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	22,414	3,128	-237	-610	2,406	87	-604	-756
Enterprise Value (EV)	14,404	22,818	22,272	28,293	38,826	29,446	33,262	29,526	26,375	29,433	27,022
Market Capitalization	13,689	22,818	21,366	18,682	27,234	19,395	26,290	22,127	17,320	21,239	19,279
Book Value per Share	$0.11	$0.12	$0.13	$34.86	$38.25	$41.88	$48.58	$54.78	$51.00	$51.68	$50.83
Tangible Book Value per Share	$0.11	$0.12	$0.13	($10.22)	($10.78)	($6.64)	$1.80	$8.17	$6.07	$7.58	$8.41
Total Capital	757	43	951	22,684	26,026	26,725	27,202	28,132	27,761	28,301	27,057
Total Debt	715	0.00	906	9,873	11,932	11,339	9,348	8,321	9,506	9,787	8,830
Total Long-Term Debt	0.00	0.00	0.00	7,962	9,830	10,791	8,281	7,862	7,611	9,713	7,921
Net Debt	715	0.00	906	9,603	11,448	9,919	6,841	7,290	8,933	8,070	7,601
Capital Expenditures (CapEx)	854	695	1,069	1,200	1,259	1,199	1,209	1,887	1,939	1,132	726
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	0.00	0.00	2,298	3,095	2,492	2,057	3,745	3,545	3,321	3,207
Debt-free Net Working Capital (DFNWC)	0.00	0.00	0.00	2,568	3,579	3,912	4,564	4,776	4,118	5,038	4,436
Net Working Capital (NWC)	-715	0.00	-906	657	1,477	3,364	3,497	4,317	2,223	4,964	3,527
Net Nonoperating Expense (NNE)	158	160	198	318	332	267	269	204	373	239	217
Net Nonoperating Obligations (NNO)	-42	-43	-45	9,603	11,448	9,919	6,841	7,290	8,933	8,070	7,601
Total Depreciation and Amortization (D&A)	711	705	761	943	1,098	1,192	1,214	1,202	1,339	1,400	1,361
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	5.74%	7.30%	5.77%	4.37%	7.03%	6.70%	6.23%	5.89%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	6.41%	8.44%	9.06%	9.70%	8.96%	7.79%	9.45%	8.15%
Net Working Capital to Revenue	-1.73%	0.00%	-2.37%	1.64%	3.48%	7.79%	7.43%	8.10%	4.20%	9.31%	6.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.85	$0.00	$0.00	$0.00	$0.00	$0.00	$16.27	$17.43	$0.00	$0.00	$2.59
Adjusted Weighted Average Basic Shares Outstanding	405M	0.00	0.00	0.00	365.19M	0.00	363M	360M	0.00	0.00	355M
Adjusted Diluted Earnings per Share	$2.95	$0.00	$0.00	$0.00	$5.52	$0.00	$8.34	$8.92	($1.87)	$2.25	$1.33
Adjusted Weighted Average Diluted Shares Outstanding	413M	0.00	0.00	0.00	366M	0.00	365M	363M	284M	356M	357M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	365.66M	0.00	0.00	0.00	365.19M	0.00	364.78M	359.59M	355.24M	0.00	353.05M
Normalized Net Operating Profit after Tax (NOPAT)	1,382	1,932	1,976	2,078	2,325	2,338	3,329	3,453	270	1,061	950
Normalized NOPAT Margin	3.34%	5.24%	5.17%	5.19%	5.48%	5.41%	7.08%	6.48%	0.51%	1.99%	1.75%
Pre Tax Income Margin	4.64%	7.04%	6.87%	6.70%	5.60%	6.17%	8.59%	7.79%	-1.28%	2.05%	1.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.53	11.41	10.39	8.64	6.11	6.47	10.42	12.32	-0.99	3.09	2.55
NOPAT to Interest Expense	4.72	7.76	7.08	9.40	5.03	4.82	7.78	9.46	-0.78	2.21	1.61
EBIT Less CapEx to Interest Expense	4.61	8.62	6.56	5.21	3.39	4.00	7.60	7.15	-6.46	0.73	0.93
NOPAT Less CapEx to Interest Expense	1.80	4.97	3.25	5.97	2.31	2.35	4.95	4.29	-6.24	-0.15	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	12.01%	12.19%	17.94%	14.50%	26.94%	29.02%	20.78%	20.10%	-103.24%	83.21%	137.48%
Augmented Payout Ratio	52.45%	121.90%	66.31%	28.86%	39.59%	39.02%	22.97%	41.71%	-157.78%	89.17%	176.13%

This table displays calculated financial ratios and metrics derived from Tyson Foods' official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026	6/27/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	352,078,966.00	352,129,402.00	351,801,512.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	352,078,966.00	352,129,402.00	351,801,512.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	0.24	0.74	0.52
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.44%	-0.46%	1.62%	1.63%	2.28%	0.02%	3.98%	2.17%	5.07%	4.43%	-0.12%
EBITDA Growth	-22.54%	141.26%	3,660.00%	307.96%	46.42%	-26.81%	-12.92%	-66.00%	-35.50%	68.00%	10.81%
EBIT Growth	-49.71%	725.00%	202.62%	222.29%	123.83%	-59.00%	-17.33%	-72.57%	-61.95%	264.23%	23.02%
NOPAT Growth	-52.50%	763.17%	207.83%	224.13%	171.51%	-79.48%	-64.81%	-66.50%	-51.81%	585.48%	172.32%
Net Income Growth	-64.38%	262.64%	145.06%	182.17%	221.05%	-90.54%	-64.80%	-84.07%	-75.41%	1,785.71%	169.57%
EPS Growth	-65.91%	246.43%	145.76%	177.52%	236.67%	-95.12%	-68.52%	-87.00%	-76.24%	3,550.00%	205.88%
Operating Cash Flow Growth	70.60%	-1,857.14%	20.61%	91.02%	-20.69%	-50.41%	-2.76%	-13.29%	-8.63%	38.92%	-17.31%
Free Cash Flow Firm Growth	153.19%	-201.58%	212.43%	344.79%	-32.53%	101.51%	-33.32%	-11.48%	41.13%	159.35%	3.57%
Invested Capital Growth	-3.64%	1,207.51%	-3.19%	-2.22%	-1.29%	-1.46%	-2.51%	-2.84%	-3.42%	-3.09%	-2.06%
Revenue Q/Q Growth	-0.22%	-1.85%	2.15%	1.59%	0.43%	-4.03%	6.20%	-0.17%	3.27%	-4.61%	1.57%
EBITDA Q/Q Growth	300.32%	3.18%	9.71%	-8.29%	41.04%	-48.43%	30.53%	-64.19%	167.57%	34.34%	-13.91%
EBIT Q/Q Growth	154.35%	17.19%	17.33%	63.64%	-0.52%	-78.53%	136.59%	-45.70%	37.97%	105.50%	-20.09%
NOPAT Q/Q Growth	150.47%	39.07%	16.14%	52.29%	10.39%	-89.49%	99.19%	44.98%	58.81%	49.47%	-20.87%
Net Income Q/Q Growth	125.73%	29.82%	32.43%	85.71%	0.55%	-96.17%	392.86%	-15.94%	55.17%	193.33%	-29.55%
EPS Q/Q Growth	123.26%	36.67%	31.71%	85.19%	1.00%	-98.02%	750.00%	-23.53%	84.62%	204.17%	-28.77%
Operating Cash Flow Q/Q Growth	302.48%	-109.46%	747.15%	-22.49%	67.10%	-117.94%	518.38%	-30.88%	76.07%	-112.00%	666.37%
Free Cash Flow Firm Q/Q Growth	383.04%	-2,610.52%	103.91%	-11.82%	-21.98%	-43.87%	72.68%	17.06%	24.39%	3.15%	-31.04%
Invested Capital Q/Q Growth	-2.60%	1.96%	-1.29%	-0.26%	-1.67%	1.78%	-2.33%	-0.61%	-2.25%	2.13%	-1.29%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	6.18%	6.62%	6.58%	7.81%	8.04%	4.59%	8.22%	5.24%	5.65%	7.05%	6.64%
EBITDA Margin	4.72%	4.96%	5.33%	4.81%	6.76%	3.63%	4.47%	1.60%	4.15%	5.84%	4.95%
Operating Margin	1.73%	2.39%	2.55%	3.87%	4.26%	0.76%	1.87%	1.14%	2.11%	3.19%	2.61%
EBIT Margin	1.92%	2.30%	2.64%	4.25%	4.21%	0.94%	2.10%	1.14%	1.52%	3.28%	2.58%
Profit (Net Income) Margin	0.86%	1.13%	1.47%	2.68%	2.69%	0.11%	0.50%	0.42%	0.63%	1.93%	1.34%
Tax Burden Percent	70.81%	72.91%	77.47%	76.63%	76.57%	46.67%	35.75%	85.29%	70.87%	73.54%	69.92%
Interest Burden Percent	62.89%	67.67%	71.88%	82.47%	83.42%	24.39%	66.32%	43.04%	58.26%	80.13%	74.30%
Effective Tax Rate	29.19%	27.09%	22.53%	23.37%	23.43%	53.33%	64.25%	14.71%	29.13%	26.46%	30.08%
Return on Invested Capital (ROIC)	2.41%	7.49%	3.88%	5.88%	6.64%	0.71%	1.38%	2.02%	3.21%	4.98%	3.95%
ROIC Less NNEP Spread (ROIC-NNEP)	1.79%	4.97%	3.08%	5.43%	5.65%	0.33%	1.08%	1.04%	1.51%	4.27%	3.04%
Return on Net Nonoperating Assets (RNNOA)	0.75%	1.71%	1.42%	2.51%	2.40%	0.15%	0.47%	0.44%	0.60%	1.82%	1.23%
Return on Equity (ROE)	3.15%	9.20%	5.29%	8.39%	9.05%	0.86%	1.85%	2.46%	3.81%	6.80%	5.18%
Cash Return on Invested Capital (CROIC)	2.07%	-109.73%	3.62%	6.19%	6.39%	5.86%	6.39%	5.65%	5.24%	5.98%	5.64%
Operating Return on Assets (OROA)	2.77%	6.48%	3.76%	6.17%	6.09%	1.37%	3.06%	1.68%	2.29%	5.12%	3.99%
Return on Assets (ROA)	1.23%	3.20%	2.09%	3.90%	3.89%	0.16%	0.73%	0.62%	0.95%	3.02%	2.07%
Return on Common Equity (ROCE)	3.13%	9.14%	5.26%	8.34%	8.98%	0.86%	1.83%	2.45%	3.78%	6.76%	5.15%
Return on Equity Simple (ROE_SIMPLE)	-4.71%	-3.41%	0.08%	0.00%	5.80%	5.11%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	164	227	264	402	444	47	93	135	214	320	253
NOPAT Margin	1.23%	1.74%	1.98%	2.97%	3.26%	0.36%	0.67%	0.97%	1.50%	2.34%	1.83%
Net Nonoperating Expense Percent (NNEP)	0.62%	2.52%	0.80%	0.45%	0.99%	0.39%	0.30%	0.98%	1.70%	0.71%	0.91%
Return On Investment Capital (ROIC_SIMPLE)	0.58%	-	-	-	1.56%	0.17%	0.34%	0.50%	0.81%	1.22%	0.97%
Cost of Revenue to Revenue	93.82%	93.38%	93.42%	92.19%	91.96%	95.41%	91.78%	94.76%	94.35%	92.95%	93.36%
SG&A Expenses to Revenue	4.44%	4.24%	4.02%	3.94%	3.78%	3.82%	3.88%	4.10%	3.54%	3.86%	4.03%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.44%	4.24%	4.02%	3.94%	3.78%	3.82%	6.35%	4.10%	3.54%	3.86%	4.03%
Earnings before Interest and Taxes (EBIT)	256	300	352	576	573	123	291	158	218	448	358
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	629	649	712	653	921	475	620	222	594	798	687
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.02	1.15	1.13	1.15	1.11	1.21	1.07	1.07	1.15	1.24	1.14
Price to Tangible Book Value (P/TBV)	8.32	9.32	8.67	7.88	7.12	7.78	6.17	6.44	6.96	7.26	6.58
Price to Revenue (P/Rev)	0.35	0.39	0.38	0.40	0.38	0.41	0.36	0.35	0.38	0.40	0.37
Price to Earnings (P/E)	0.00	0.00	0.00	26.55	19.61	24.31	25.10	40.67	103.37	49.68	35.92
Dividend Yield	3.71%	3.33%	3.41%	3.28%	3.40%	3.17%	3.60%	3.69%	3.43%	3.16%	3.47%
Earnings Yield	0.00%	0.00%	0.00%	3.77%	5.10%	4.11%	3.98%	2.46%	0.97%	2.01%	2.78%
Enterprise Value to Invested Capital (EV/IC)	1.01	1.10	1.09	1.11	1.08	1.14	1.05	1.05	1.11	1.17	1.10
Enterprise Value to Revenue (EV/Rev)	0.51	0.56	0.54	0.55	0.53	0.57	0.50	0.50	0.51	0.54	0.50
Enterprise Value to EBITDA (EV/EBITDA)	47.52	31.42	17.26	10.21	9.63	11.02	10.24	10.78	14.60	13.51	12.16
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	66.18	19.83	15.70	18.73	17.48	23.60	35.32	27.08	23.68
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	279.37	27.75	21.09	25.88	26.98	37.33	61.57	40.59	30.53
Enterprise Value to Operating Cash Flow (EV/OCF)	11.70	13.73	12.60	11.36	12.18	13.47	12.22	12.54	13.50	14.12	13.97
Enterprise Value to Free Cash Flow (EV/FCFF)	48.01	0.00	29.50	17.68	16.82	19.38	16.26	18.26	20.71	19.27	19.28
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.60	0.61	0.53	0.53	0.49	0.49	0.48	0.46	0.44	0.44
Long-Term Debt to Equity	0.46	0.53	0.53	0.52	0.52	0.44	0.44	0.43	0.41	0.44	0.36
Financial Leverage	0.42	0.34	0.46	0.46	0.43	0.46	0.44	0.43	0.40	0.43	0.40
Leverage Ratio	1.93	2.05	2.01	1.99	2.01	2.01	2.02	2.01	1.99	1.95	1.97
Compound Leverage Factor	1.21	1.39	1.44	1.65	1.67	0.49	1.34	0.86	1.16	1.56	1.46
Debt to Total Capital	34.61%	37.56%	37.71%	34.58%	34.49%	32.86%	32.92%	32.63%	31.53%	30.75%	30.57%
Short-Term Debt to Total Capital	4.68%	4.51%	4.52%	0.26%	0.33%	3.25%	3.22%	3.36%	3.43%	0.54%	5.45%
Long-Term Debt to Total Capital	29.93%	33.05%	33.20%	34.32%	34.15%	29.61%	29.71%	29.28%	28.10%	30.22%	25.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.49%	0.46%	0.43%	0.44%	0.44%	0.47%	0.47%	0.52%	0.53%	0.39%	0.40%
Common Equity to Total Capital	64.90%	61.98%	61.86%	64.98%	65.08%	66.67%	66.60%	66.84%	67.95%	68.86%	69.03%
Debt to EBITDA	17.16	11.61	6.58	3.39	3.34	3.28	3.40	3.52	4.38	3.62	3.48
Net Debt to EBITDA	14.53	9.30	5.04	2.80	2.56	2.93	2.82	3.03	3.71	3.39	3.16
Long-Term Debt to EBITDA	14.84	10.22	5.79	3.37	3.31	2.96	3.06	3.16	3.90	3.56	2.86
Debt to NOPAT	-21.91	-57.99	106.46	9.23	7.32	7.71	8.95	12.20	18.45	10.87	8.73
Net Debt to NOPAT	-18.55	-46.44	81.64	7.61	5.61	6.87	7.42	10.50	15.63	10.20	7.93
Long-Term Debt to NOPAT	-18.95	-51.03	93.71	9.16	7.25	6.95	8.08	10.94	16.45	10.68	7.18
Altman Z-Score	2.88	2.92	2.91	3.05	3.04	3.09	3.03	2.95	3.08	3.30	3.14
Noncontrolling Interest Sharing Ratio	0.76%	0.73%	0.69%	0.67%	0.71%	0.72%	0.70%	0.72%	0.72%	0.64%	0.64%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.49	1.77	1.82	2.04	2.11	1.67	1.73	1.55	1.53	1.83	1.43
Quick Ratio	0.61	0.81	0.85	0.86	0.97	0.61	0.70	0.59	0.60	0.60	0.48
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,164	-29,212	1,141	1,006	785	441	761	891	1,108	1,143	788
Operating Cash Flow to CapEx	367.23%	-46.07%	302.66%	248.79%	380.44%	-95.85%	340.97%	186.41%	448.57%	-79.02%	402.52%
Free Cash Flow to Firm to Interest Expense	11.08	-263.17	8.45	7.74	6.54	4.01	6.73	8.40	10.65	11.78	8.04
Operating Cash Flow to Interest Expense	12.38	-1.11	5.90	4.75	8.59	-1.68	6.85	5.05	9.06	-1.16	6.53
Operating Cash Flow Less CapEx to Interest Expense	9.01	-3.51	3.95	2.84	6.33	-3.44	4.84	2.34	7.04	-2.64	4.91
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.44	2.82	1.43	1.45	1.45	1.45	1.46	1.48	1.50	1.56	1.55
Accounts Receivable Turnover	23.23	0.00	21.94	21.84	23.38	22.61	22.36	22.09	23.20	23.29	22.68
Inventory Turnover	9.45	0.00	9.61	9.44	9.75	9.57	9.60	9.36	9.86	9.58	9.27
Fixed Asset Turnover	5.63	0.00	5.59	5.59	5.64	5.68	5.87	5.84	5.99	6.12	6.23
Accounts Payable Turnover	19.58	0.00	21.25	19.89	19.42	21.76	21.55	20.34	19.87	21.62	20.37
Days Sales Outstanding (DSO)	15.71	0.00	16.64	16.71	15.61	16.14	16.32	16.53	15.73	15.67	16.09
Days Inventory Outstanding (DIO)	38.64	0.00	38.00	38.65	37.45	38.16	38.02	39.01	37.02	38.11	39.36
Days Payable Outstanding (DPO)	18.64	0.00	17.18	18.35	18.80	16.77	16.94	17.95	18.37	16.88	17.92
Cash Conversion Cycle (CCC)	35.72	0.00	37.46	37.02	34.26	37.53	37.41	37.59	34.38	36.90	37.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	26,482	27,001	26,654	26,584	26,141	26,607	25,986	25,828	25,247	25,784	25,451
Invested Capital Turnover	1.96	4.31	1.96	1.98	2.04	2.00	2.06	2.08	2.15	2.13	2.17
Increase / (Decrease) in Invested Capital	-1,000	29,439	-877	-604	-341	-394	-668	-756	-894	-823	-535
Enterprise Value (EV)	26,803	29,661	28,921	29,433	28,267	30,423	27,326	27,022	27,899	30,191	27,989
Market Capitalization	18,471	20,749	20,343	21,239	20,629	22,216	19,678	19,279	20,675	22,505	20,617
Book Value per Share	$51.09	$50.76	$50.77	$51.68	$51.99	$51.66	$51.48	$50.83	$51.05	$51.40	$51.34
Tangible Book Value per Share	$6.25	$6.25	$6.59	$7.58	$8.15	$8.02	$8.95	$8.41	$8.42	$8.80	$8.90
Total Capital	27,966	29,183	29,223	28,301	28,433	27,599	27,533	27,057	26,525	26,284	26,191
Total Debt	9,678	10,960	11,021	9,787	9,806	9,068	9,065	8,830	8,362	8,083	8,006
Total Long-Term Debt	8,370	9,645	9,701	9,713	9,711	8,172	8,179	7,921	7,453	7,942	6,579
Net Debt	8,194	8,778	8,452	8,070	7,514	8,076	7,518	7,601	7,084	7,583	7,266
Capital Expenditures (CapEx)	354	267	263	248	271	193	227	287	210	143	159
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,868	3,466	3,513	3,321	3,105	3,578	3,508	3,207	2,940	3,667	3,548
Debt-free Net Working Capital (DFNWC)	4,352	5,648	6,082	5,038	5,397	4,570	5,055	4,436	4,218	4,167	4,288
Net Working Capital (NWC)	3,044	4,333	4,762	4,964	5,302	3,674	4,169	3,527	3,309	4,026	2,861
Net Nonoperating Expense (NNE)	50	79	68	38	78	33	24	77	124	56	67
Net Nonoperating Obligations (NNO)	8,194	8,778	8,452	8,070	7,514	8,076	7,518	7,601	7,084	7,583	7,266
Total Depreciation and Amortization (D&A)	373	349	360	77	348	352	329	64	376	350	329
Debt-free, Cash-free Net Working Capital to Revenue	5.42%	6.55%	6.62%	6.23%	5.79%	6.67%	6.48%	5.89%	5.33%	6.58%	6.37%
Debt-free Net Working Capital to Revenue	8.22%	10.68%	11.46%	9.45%	10.07%	8.52%	9.34%	8.15%	7.65%	7.48%	7.70%
Net Working Capital to Revenue	5.75%	8.19%	8.97%	9.31%	9.89%	6.85%	7.70%	6.48%	6.00%	7.23%	5.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.59	$0.00	$1.04	$0.00	$1.96	$0.00	$0.34	$0.29	$0.47	$1.43	$0.00
Adjusted Weighted Average Basic Shares Outstanding	354M	0.00	354M	0.00	355M	0.00	355M	355M	352M	353M	0.00
Adjusted Diluted Earnings per Share	$0.30	$0.41	$0.54	$1.00	$1.01	$0.02	$0.17	$0.13	$0.24	$0.73	$0.52
Adjusted Weighted Average Diluted Shares Outstanding	355M	355M	356M	356M	357M	357M	357M	357M	354M	354M	355M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	356.35M	356.02M	355.83M	0.00	356.19M	356.23M	355.77M	353.05M	352.08M	352.13M	351.80M
Normalized Net Operating Profit after Tax (NOPAT)	164	227	264	402	444	70	422	135	214	320	253
Normalized NOPAT Margin	1.23%	1.74%	1.98%	2.97%	3.26%	0.54%	3.04%	0.97%	1.50%	2.34%	1.83%
Pre Tax Income Margin	1.21%	1.55%	1.89%	3.50%	3.51%	0.23%	1.39%	0.49%	0.89%	2.63%	1.92%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.44	2.70	2.61	4.43	4.78	1.12	2.58	1.49	2.10	4.62	3.65
NOPAT to Interest Expense	1.56	2.05	1.96	3.09	3.70	0.42	0.82	1.27	2.06	3.30	2.58
EBIT Less CapEx to Interest Expense	-0.93	0.30	0.66	2.52	2.52	-0.64	0.57	-1.22	0.08	3.14	2.03
NOPAT Less CapEx to Interest Expense	-1.81	-0.36	0.01	1.19	1.44	-1.33	-1.19	-1.44	0.04	1.82	0.96
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-78.60%	-109.74%	4,533.33%	83.21%	64.06%	73.51%	85.49%	137.48%	302.60%	145.74%	117.39%
Augmented Payout Ratio	-84.91%	-118.34%	4,900.00%	89.17%	68.81%	77.13%	91.27%	176.13%	401.30%	202.29%	163.71%

Financials Breakdown Chart

Key Financial Trends

Tyson Foods (NYSE: TSN) has shown a meaningful earnings recovery from the losses recorded in 2023, although recent results remain uneven. Revenue in Q3 2026 was $13.87 billion, essentially flat with Q3 2025 and 3.6% above Q3 2024. However, the company’s profitability has not returned to the stronger levels seen in 2022. Q3 2026 gross profit was $921 million, representing a 6.6% gross margin, compared with $1.61 billion and an 11.9% margin in Q3 2022.

Operating income improved to $362 million in Q3 2026 from $260 million in Q3 2025, while net income attributable to common shareholders rose to $182 million from $61 million. That said, Q3 earnings declined sequentially from $260 million in Q2 2026, and diluted earnings per share fell from $0.73 to $0.52. The figures also include several restated historical periods, so investors should focus on the overall direction rather than isolated quarter-to-quarter comparisons.

Cash flow remains an important strength. Tyson generated $640 million of operating cash flow in Q3 2026 after producing negative operating cash flow of $113 million in Q2. Year-to-date operating cash flow was approximately $1.47 billion, more than covering $556 million of capital expenditures. This allowed the company to fund dividends, repurchases and debt repayments while still increasing cash by $240 million during the latest quarter.

Earnings have recovered substantially. Q3 2026 net income attributable to common shareholders reached $182 million, compared with $61 million in Q3 2025 and a $417 million loss in Q3 2023.
Operating cash flow rebounded sharply. Tyson generated $640 million in Q3 2026 after a $113 million outflow in Q2, bringing year-to-date operating cash flow to roughly $1.47 billion.
Free cash flow supports shareholder returns. Year-to-date operating cash flow exceeded capital spending by about $914 million, providing room for $529 million of dividends and share repurchases through the first three quarters.
Debt levels have improved from 2024 and early 2026. Short- and long-term debt totaled approximately $8.0 billion at the end of Q3 2026, down from $9.1 billion in Q3 2025 and $8.36 billion in Q1 2026.
Interest expense is trending lower. Quarterly interest expense declined to $98 million in Q3 2026 from $106 million in Q4 2024 and $120 million in Q1 2025, helping support pretax earnings.
Revenue growth is modest. Quarterly revenue has remained in a relatively narrow range of roughly $13.1 billion to $14.3 billion over the available periods, suggesting that future earnings gains will depend more on margins and cost control than on rapid sales growth.
Capital spending has moderated. Q3 2026 capital expenditures were $159 million, below the $252 million recorded in Q1 and $287 million in Q4 2025. This benefits near-term cash flow, but investors should determine whether the lower spending reflects efficiency or deferred investment.
Profit margins remain below prior-year highs. The Q3 2026 gross margin was approximately 6.6%, down from 8.2% in Q3 2025 and far below the 11.9% reported in Q3 2022.
Cash and liquidity have weakened over the longer term. Cash and equivalents fell to $740 million in Q3 2026 from $1.55 billion in Q3 2025 and $2.57 billion in Q3 2024. Although current assets exceeded current liabilities, the company’s cash cushion is considerably smaller than it was in earlier periods.
Inventory and balance-sheet concentration remain risks. Inventory increased to $5.84 billion in Q3 2026, or more than 60% of current assets. Tyson also carried approximately $15.0 billion of goodwill and intangible assets, making future impairments a potential source of earnings volatility.

Overall, Tyson’s financial profile is improving from the severe weakness seen in 2023. Debt reduction, lower interest expense and strong year-to-date cash generation are constructive for shareholders. However, the recent sequential earnings decline, lower gross margins, reduced cash balance and elevated inventory levels indicate that the recovery is not yet fully established. Retail investors should watch whether Tyson can sustain operating cash flow while rebuilding margins and reducing its reliance on working-capital improvements.

08/31/26 05:40 AM ETAI Generated. May Contain Errors.

Tyson Foods Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Tyson Foods' financial year ends in September. Their financial year 2025 ended on September 27, 2025.

Tyson Foods' net income appears to be on a downward trend, with a most recent value of $507 million in 2025, falling from $1.22 billion in 2015. The previous period was $822 million in 2024. Find out what analysts predict for Tyson Foods in the coming months.

Tyson Foods' total operating income in 2025 was $1.10 billion, based on the following breakdown:

Total Gross Profit: $3.56 billion
Total Operating Expenses: $2.46 billion

Over the last 10 years, Tyson Foods' total revenue changed from $41.37 billion in 2015 to $54.44 billion in 2025, a change of 31.6%.

Tyson Foods' total liabilities were at $18.43 billion at the end of 2025, a 0.8% decrease from 2024, and a 2,477.8% increase since 2015.

In the past 10 years, Tyson Foods' cash and equivalents has ranged from $0.00 in 2015 to $2.51 billion in 2021, and is currently $1.23 billion as of their latest financial filing in 2025.

Over the last 10 years, Tyson Foods' book value per share changed from 0.11 in 2015 to 50.83 in 2025, a change of 45,206.1%.

Related Companies

Financial statements for NYSE:TSN last updated on 8/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tyson Foods (TSN) Financials

Financials Breakdown Chart

Key Financial Trends

Tyson Foods Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tyson Foods (TSN) Financials

Annual Income Statements for Tyson Foods

Quarterly Income Statements for Tyson Foods

Annual Cash Flow Statements for Tyson Foods

Quarterly Cash Flow Statements for Tyson Foods

Annual Balance Sheets for Tyson Foods

Quarterly Balance Sheets for Tyson Foods

Annual Metrics And Ratios for Tyson Foods

Quarterly Metrics And Ratios for Tyson Foods

Financials Breakdown Chart

Key Financial Trends

Tyson Foods Financials - Frequently Asked Questions

When does Tyson Foods' fiscal year end?

How has Tyson Foods' net income changed over the last 10 years?

What is Tyson Foods' operating income?

How has Tyson Foods' revenue changed over the last 10 years?

How much debt does Tyson Foods have?

How much cash does Tyson Foods have?

How has Tyson Foods' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools